BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Suresh RR, Jain S, Chen Z, Tosh DK, Ma Y, Podszun MC, Rotman Y, Salvemini D, Jacobson KA. Design and in vivo activity of A3 adenosine receptor agonist prodrugs. Purinergic Signal 2020;16:367-77. [PMID: 32720036 DOI: 10.1007/s11302-020-09715-0] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
Number Citing Articles
1 Coppi E, Cherchi F, Venturini M, Lucarini E, Corradetti R, Di Cesare Mannelli L, Ghelardini C, Pedata F, Pugliese AM. Therapeutic Potential of Highly Selective A3 Adenosine Receptor Ligands in the Central and Peripheral Nervous System. Molecules 2022;27:1890. [PMID: 35335254 DOI: 10.3390/molecules27061890] [Reference Citation Analysis]
2 Kotulova J, Lonova K, Kubickova A, Vrbkova J, Kourilova P, Hajduch M, Dzubak P. 2‑Cl‑IB‑MECA regulates the proliferative and drug resistance pathways, and facilitates chemosensitivity in pancreatic and liver cancer cell lines. Int J Mol Med 2022;49:31. [PMID: 35039871 DOI: 10.3892/ijmm.2022.5086] [Reference Citation Analysis]
3 Mazziotta C, Rotondo JC, Lanzillotti C, Campione G, Martini F, Tognon M. Cancer biology and molecular genetics of A3 adenosine receptor. Oncogene 2021. [PMID: 34750517 DOI: 10.1038/s41388-021-02090-z] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Jain S, Jacobson KA. Purinergic Signaling in Liver Pathophysiology. Front Endocrinol (Lausanne) 2021;12:718429. [PMID: 34456873 DOI: 10.3389/fendo.2021.718429] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Coppi E, Cherchi F, Lucarini E, Ghelardini C, Pedata F, Jacobson KA, Di Cesare Mannelli L, Pugliese AM, Salvemini D. Uncovering the Mechanisms of Adenosine Receptor-Mediated Pain Control: Focus on the A3 Receptor Subtype. Int J Mol Sci 2021;22:7952. [PMID: 34360719 DOI: 10.3390/ijms22157952] [Reference Citation Analysis]
6 Barella LF, Jain S, Kimura T, Pydi SP. Metabolic roles of G protein-coupled receptor signaling in obesity and type 2 diabetes. FEBS J 2021;288:2622-44. [PMID: 33682344 DOI: 10.1111/febs.15800] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
7 Jain S, Jacobson KA. Purinergic signaling in diabetes and metabolism. Biochem Pharmacol 2021;187:114393. [PMID: 33359363 DOI: 10.1016/j.bcp.2020.114393] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
8 Vincenzi F, Pasquini S, Borea PA, Varani K. Targeting Adenosine Receptors: A Potential Pharmacological Avenue for Acute and Chronic Pain. Int J Mol Sci 2020;21:E8710. [PMID: 33218074 DOI: 10.3390/ijms21228710] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]